Breaking News

BioMedX Initiates New Oncology Research Project with Merck

Aims to develop an atlas of extrachromosomal DNA in human cancer tissues and thereby trace back the mechanisms of ecDNA formation and function.

Author Image

By: Charlie Sternberg

Associate Editor

BioMed X, a German independent research institute, has started its new research project ‘Extrachromosomal DNA in Cancer’ (EDC) in collaboration with Healthcare Business of Merck KGaA, Darmstadt, Germany.   The main objective of this research group is to develop an atlas of extrachromosomal DNA (ecDNA) in human cancer tissues and thereby trace back the mechanisms of ecDNA formation and function.   Like the name suggests, extrachromosomal DNA refers to DNA sequences that are not located on chr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters